EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies

SIMPLE SUMMARY: Cisplatin is a chemotherapy drug widely used in the treatment of different cancer types. However, cisplatin displays a high range of toxicity and its use usually leads to resistance. Therefore, combination therapies that include cisplatin are explored to alleviate the problems that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Samaržija, Ivana, Tomljanović, Marko, Novak Kujundžić, Renata, Trošelj, Koraljka Gall
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561994/
https://www.ncbi.nlm.nih.gov/pubmed/36230683
http://dx.doi.org/10.3390/cancers14194761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561994/
https://www.ncbi.nlm.nih.gov/pubmed/36230683
http://dx.doi.org/10.3390/cancers14194761

Ejemplares similares